Details for 2014173342
Up to date per 04.04.2026
Actions
Details for 2014173342
Granted/Registered
European Patent
26.11.2014 A
07.08.2019 B1
28.05.2008
US
56715 P
A61K 31/575 20060101AFI20141021BHEP
Owner
ReveraGen BioPharma, Inc.155 Gibbs Street, Suite 433 Rockville, MD 20850US
Representative
Representative
Schwarz & Partner Patentanwälte OGWipplingerstraße 301010 WienAT
Inventor
Mccall, John, M.3910 Warner Street Kensington, MD 20895US
Hoffman, Eric3910 Warner Street Kensington, MD 20895US
Kanneboyina, Nagaraju3910 Warner Street Kensington, MD 20895US
Information about Fees